A comparative study of C-reactive protein levels in patients with major depressive disorder with and without suicidal attempts
DOI:
https://doi.org/10.15584/ejcem.2026.1.13Keywords:
C-reactive protein, depressive patients, major depressive disorder, pro-inflammatory marker, suicidal behaviorAbstract
Introduction and aim. Major depressive disorder (MDD) is closely linked to suicidal behavior, and systemic inflammation ‒ particularly elevated C-reactive protein (CRP) ‒ has been proposed as a contributing factor. However, evidence comparing CRP patterns separately in suicide attempters and non-attempters remains limited, especially in underrepresented populations. The aim of this study was to compare serum CRP levels in patients with MDD with and without a history of suicide attempts.
Material and methods. This cross-sectional analytical study included 60 adults diagnosed with MDD according to ICD-10 criteria. Participants were divided into two groups: those with a history of suicide attempts (n=30) and those without such a history (n=30). Depression severity was assessed using the Hamilton Depression Rating Scale (HAM-D). Serum CRP levels were measured using a turbidimetric method. Statistical analyses included Student’s t-test, Mann-Whitney U-test, and Pearson’s correlation.
Results. CRP levels were significantly higher among suicide attempters compared with non-attempters (4.47±3.53 mg/L vs 2.50±3.59 mg/L; p=0.03). A significant positive correlation between HAM-D scores and CRP levels was observed in the suicide-attempt group (R=0.52; p=0.003), whereas no such correlation was found in non-attempters (R=0.12; p=0.52). Severe depression was more common among suicide attempters (30/44 cases).
Conclusion. This study provides novel evidence that the association between inflammation and depressive symptom severity is present only in patients with a history of suicidal behavior. Elevated CRP may therefore represent a potential marker for identifying MDD patients at increased risk of suicide.
Downloads
References
World Health Organization. Depression: A global crisis. 2023. In: WHO Fact Sheet. Geneva: World Health Organization. https://www.who.int/news-room/fact-sheets/detail/depression. Accessed September 20, 2024.
Global Burden of Disease Study. 2021. In: Global Burden of Disease. Seattle: Institute for Health Metrics and Evaluation. https://www.healthdata.org/gbd. Accessed September 20, 2024.
Naragon-Gainey K, Watson D. The anxiety disorders and suicidal ideation: accounting for co-morbidity via underlying personality traits. Psychol Med. 2011;41(7):1437-1447. doi:10.1017/S0033291710002096
Al-Hamzawi AO, Bruffaerts R, Bromet EJ, AlKhafaji AM, Kessler RC. The epidemiology of major depressive episode in the Iraqi general population. PLoS One. 2015;10(7):e0131937. doi:10.1371/journal.pone.0131937
Moslemi H, Fatemian H, Hosseini Y, Moshfeghinia R. C-reactive protein (CRP) level in depressed patients with suicidal behavior: a systematic review and meta-analysis. J Affect Disord. 2024:366:423-433. doi:10.1016/j.jad.2024.08.135
Ceciliani F, Giordano A, Spagnolo V. The systemic reaction during inflammation: the acute-phase proteins. Protein Pept Lett. 2002;9(3):211-223. doi:10.2174/0929866023408779
De Berardis D, Conti CM, Marini S, et al. C-reactive protein level and its relationship with suicide risk and alexithymia among newly diagnosed, drug-naïve patients with non-affective psychosis. Eur J Inflamm. 2013;11(1):215-221. doi:10.1177/1721727X1301100120
Loas G, Dalleau E, Lecointe H, Yon V. Relationships between anhedonia, alexithymia, impulsivity, suicidal ideation, recent suicide attempt, C-reactive protein, and serum lipid levels among 122 inpatients with mood or anxious disorders. Psychiatry Res. 2016;246:296-302. doi:10.1016/j.psychres.2016.09.056
Gibbs HM, Davis L, Han X, Clothier J, Eads LA, Cáceda R. Association between C-reactive protein and suicidal behavior in an adult inpatient population. J Psychiatr Res. 2016;79:28-33. doi:10.1016/j.jpsychires.2016.04.002
Miola A, Dal Porto V, Tadmor T, et al. Increased C-reactive protein concentration and suicidal behavior in people with psychiatric disorders: a systematic review and meta-analysis. Acta Psychiatr Scand. 2021;144(6):537-552. doi:10.1111/acps.13351
Aguglia A, Natale A, Fusar-Poli L, et al. C-reactive protein as a potential peripheral biomarker for high-lethality suicide attempts. Life (Basel). 2022;12(10):1557. doi:10.3390/life12101557
Fernández-Sevillano J, González-Ortega I, MacDowell K, et al. Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning, and cognition. World J Biol Psychiatry. 2022;23(4):307-317. doi:10.1080/15622975.2021.1988703
Klonsky ED, May AM, Saffer BY. Suicide, suicide attempts, and suicidal ideation. Annu Rev Clin Psychol. 2016;12:307-330. doi:10.1146/annurev-clinpsy-021815-093204
Campisi SC, Carducci B, Akseer N, Zasowski C, Szatmari P, Bhutta ZA. Suicidal behaviours among adolescents from 90 countries: a pooled analysis of the global school-based student health survey. BMC Public Health. 2020;20(1):1-11. doi:10.1186/s12889-020-09209-z
Liu RT, Bettis AH, Burke TA. Characterizing the phenomenology of passive suicidal ideation: a systematic review and meta-analysis of its prevalence, psychiatric comorbidity, correlates, and comparisons with active suicidal ideation. Psychol Med. 2020;50(3):367-383. doi:10.1017/S003329171900391X
McKay T, Berzofsky M, Landwehr J, Hsieh P, Smith A. Suicide etiology in youth: differences and similarities by sexual and gender minority status. Child Youth Serv Rev. 2019;102:79-90. doi:10.1016/j.childyouth.2019.03.039
Orsolini L, Pompili S, Tempia Valenta S, Salvi V, Volpe U. C-reactive protein as a biomarker for major depressive disorder? Int J Mol Sci. 2022;23(3):1616. doi:10.3390/ijms23031616
Savita V, Pal VS, Bagul K, Mudgal V. A comparative study of picolinic acid levels in patients of severe depression with and without suicidality. Arch Med Health Sci. 2023;11(2):198-202. doi:10.4103/amhs.amhs_79_23
Grudet C, Lindqvist D, Malm J, Westrin Å, Ventorp F. 25(OH)D levels are decreased in patients with difficult-to-treat depression. Compr Psychoneuroendocrinol. 2022;10:100126. doi:10.1016/j.cpnec.2022.100126
Aguglia A, Amerio A, Asaro P, et al. High lethality of suicide attempts associated with platelet-to-lymphocyte ratio and mean platelet volume in psychiatric inpatient setting. World J Biol Psychiatry. 2021;22(2):119-127. doi:10.1080/15622975.2020.1761033
Aguglia A, Solano P, Parisi VM, et al. Predictors of relapse in high lethality suicide attempters: a six-month prospective study. J Affect Disord. 2020;271:328-335. doi:10.1016/j.jad.2020.04.006
Su YA, Ye C, Xin Q, Si T. Major depressive disorder with suicidal ideation or behavior in Chinese population: a scoping review of current evidence on disease assessment, burden, treatment, and risk factors. J Affect Disord. 2023;340:732-742. doi:10.1016/j.jad.2023.08.106
Kumar U. Handbook of Suicidal Behaviour. Singapore: Springer Singapore; 2017.
Ansar W, Ghosh S. CRP: historical perspective, structure, evolution, synthesis, clinical and biological functions. In: Biology of C Reactive Protein in Health and Disease. Singapore: Springer; 2016:33-43. doi:10.1007/978-81-322-2680-2_2
Gasparini A, Callegari C, Lucca G, Bellini A, Caselli I, Ielmini M. Inflammatory biomarker and response to antidepressant in major depressive disorder: a systematic review and meta-analysis. Psychopharmacol Bull. 2022;52(1):36.
Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med. 2019;49(12):1958-1970. doi:10.1017/S0033291719001454
Aguglia A, Solano P, Giacomini G, et al. The association between dyslipidemia and lethality of suicide attempts: a case-control study. Front Psychiatry. 2019;10:70. doi:10.3389/fpsyt.2019.00070
Toffol E, Miola A, Magnolfi G, Trevisan G, Scocco P. High hs-CRP levels after an attempted suicide: a matched case-control study. J Affect Disord Rep. 2022;10:100381. doi:10.1016/j.jadr.2022.100381
Srivastava S, Sharma B, Avasthi RK, Kotru M. Comparison between inflammatory biomarkers (high-sensitivity C-reactive protein and neutrophil-lymphocyte ratio) and psychological morbidity in suicide attempt survivors brought to medicine emergency. Cureus. 2021;13(8):e17459. doi:10.7759/cureus.17459
Baumert J, Lukaschek K, Kruse J, et al. No evidence for an association of posttraumatic stress disorder with circulating levels of CRP and IL-18 in a population-based study. Cytokine. 2013;63(2):201-208. doi:10.1016/j.cyto.2013.04.033
Pethő-Botswick Á, Kovács MÁ, Simon D, et al. Investigation of peripheral inflammatory biomarkers in association with suicide risk in major depressive disorder. Front Psychiatry. 2024;15:1321354. doi:10.3389/fpsyt.2024.1321354
Sachs-Ericsson N, Hames JL, Joiner TE, et al. Differences between suicide attempters and nonattempters in depressed older patients: depression severity, white-matter lesions, and cognitive functioning. Am J Geriatr Psychiatry. 2014;22(1):75-85. doi:10.1016/j.jagp.2013.01.063
Dumais A, Lesage AD, Alda M, et al. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry. 2005;162(11):2116-2124. doi:10.1176/appi.ajp.162.11.2116
Calati R, Bakhiyi CL, Artero S, Ilgen M, Courtet P. The impact of physical pain on suicidal thoughts and behaviors: meta-analyses. J Psychiatr Res. 2015;71:16-32. doi:10.1016/j.jpsychires.2015.09.004
Barzilay R, Lobel T, Krivoy A, Shlosberg D, Weizman A, Katz N. Elevated C-reactive protein levels in schizophrenia inpatients is associated with aggressive behavior. Eur Psychiatry. 2016;31:8-12. doi:10.1016/j.eurpsy.2015.09.461
Kim SY, Jeon SW, Lim WJ, et al. Vitamin D deficiency and suicidal ideation: a cross-sectional study of 157,211 healthy adults. J Psychosom Res. 2020;134:110125. doi:10.1016/j.jpsychores.2020.110125
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
